Mircobiome Therapeutics MarketPosted by ahila on April 26th, 2018 Global Mircobiome Therapeutics Market :A microbiome is genetic material of all microbes such as bacteria, virus, fungi and protozoa that live on and inside the human body. Every part of the body has different types of microbes. For instance, about a third bacteria in the gut are Bacteroides species, whereas Streptococcus species are dominant about oral health. Microbiomes plays the significant role in human health and disease conditions. Increase in evidence about the direct relationship of the microbiome in treating lifestyle diseases, autoimmune diseases such as Crohn’s, inflammatory bowel disease (IBS) conditions are fuelling the growth of the market. Currently, very few drugs are available in the market to treat these disease conditions. Furthermore, microbiome therapeutics are safer than conventional treatments as they are already present in human body. Microbiome therapeutics didn’t possess any side-effects, unlike conventional drugs these factors will have the positive impact on the growth of the market. However, lack of substantial clinical evidence about the microbiome benefits on human health and regulatory barriers might hamper the growth of the market over the forecast period. A sample of this report is available upon request @ Microbiome Therapeutics Market has been segmented based on Product Type, and Disease Indication Based on the product type, Microbiome Therapeutics Market has been segmented into the following:
Based on Disease Indication, Microbiome Therapeutics Market has been segmented into the following:
o o Crohn’s disease o o Inflammatory Bowel Disease (IBD) o o Irritable Bowel Syndrome (IBS) o o Others
o o Obesity o o Diabetes o o Others
To view TOC of this report is available upon request @ Like it? Share it! More by this author |